PPIs sometimes highly variable even in fasted state [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2017-02-27 12:32 (3051 d 20:31 ago) – Posting: # 17113
Views: 6,753

Dear Dan and M.tareq,

❝ the design for the fed state study does not need to be the same as for the fasted study.


Agree.

❝ In fact it would be unethical to treat more subjects in the fasted study in a more elaborated design than you would need to demonstrate bioequivalence.


When it comes to PPIs I only partly agree. There are no safety concerns (in some contries some PPIs are even available OTC). Sometimes PPIs show a CVwR >30% even in fasted state. IMHO, I could make sense to design both studies in a replicate design – though the sample size could be different.

❝ ❝ i.e partial replicate ?


The partial replicate is lousy design (search the forum…). See this post why a 4-period full replicate is preferable over 3-period replicates.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,681 registered users;
51 visitors (0 registered, 51 guests [including 18 identified bots]).
Forum time: 10:04 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5